These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 6549001)

  • 1. Chryscandin, a novel peptidyl nucleoside antibiotic. II. Structure determination and synthesis.
    Yamashita M; Kawai Y; Uchida I; Komori T; Kohsaka M; Imanaka H; Sakane K; Setoi H; Teraji T
    J Antibiot (Tokyo); 1984 Nov; 37(11):1284-93. PubMed ID: 6549001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chryscandin, a novel peptidyl nucleoside antibiotic. I. Taxonomy, fermentation, isolation and characterization.
    Yamashita M; Tsurumi Y; Hosoda J; Komori T; Kohsaka M; Imanaka H
    J Antibiot (Tokyo); 1984 Nov; 37(11):1279-83. PubMed ID: 6549000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure activity relationships of synthetic antibiotic analogues of chryscandin.
    Komori T; Sakane K; Setoi H; Kawai Y; Teraji T; Kohsaka M; Imanaka H
    J Antibiot (Tokyo); 1985 Sep; 38(9):1182-203. PubMed ID: 3840797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural investigations of mode of action of drugs: structure and conformation of a novel peptidyl nucleoside antibiotic chryscandin hydrochloride pentahydrate.
    Liu M; Arora SK
    J Antibiot (Tokyo); 2008 May; 61(5):322-5. PubMed ID: 18653999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complex peptidyl nucleoside antibiotics: efficient syntheses of the glycosyl nucleoside amino acid cores.
    Bhaket P; Stauffer CS; Datta A
    J Org Chem; 2004 Dec; 69(25):8594-601. PubMed ID: 15575734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthetic design, stereochemistry, and enzymatic activity of a reversed aminoacyl nucleoside: an analogue of puromycin.
    Nair V; Emanuel DJ
    J Am Chem Soc; 1977 Mar; 99(5):1571-6. PubMed ID: 839005
    [No Abstract]   [Full Text] [Related]  

  • 7. 5'Chloropuromycin. Inhibition of protein synthesis and antitrypanosomal activity.
    Vince R; Lee H; Narang AS; Shirota FN
    J Med Chem; 1981 Dec; 24(12):1511-4. PubMed ID: 7310828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolism of puromycin aminonucleoside in transformed human lung fibroblasts and the mechanism of its inhibition of RNA synthesis.
    Albanese EA; Studzinski GP
    Mol Pharmacol; 1980 Mar; 17(2):262-7. PubMed ID: 6993915
    [No Abstract]   [Full Text] [Related]  

  • 9. Synthesis, stereochemical characterization, and antimicrobial evaluation of a potentially nonnephrotoxic 3'-C-acethydrazide puromycin analog.
    Carter J; Weaver BA; Chiacchio MA; Messersmith AR; Lynch WE; Feske BD; Gumina G
    Nucleosides Nucleotides Nucleic Acids; 2017 Mar; 36(3):224-241. PubMed ID: 28102767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of aminonucleoside, daunomycin, and adriamycin on carbon oxidation by glomeruli.
    Kaplan BS; Renaud L; Drummond KN
    Lab Invest; 1976 Feb; 34(2):174-8. PubMed ID: 1249918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An active puromycin analog derived from a non-nephrotoxic aminonucleoside.
    Vince R; Almquist RG; Ritter CL; Shirota FN; Nagasawa HT
    Life Sci; 1976 Feb; 18(3):345-9. PubMed ID: 768682
    [No Abstract]   [Full Text] [Related]  

  • 12. Selective inhibition of preribosomal RNA synthesis by puromycin aminonucleoside in transformed human fibroblasts: studies of the nature of the inhibition in isolated nuclei and nucleoli.
    Albanese EA; Studzinski GP
    J Cell Physiol; 1979 Apr; 99(1):55-65. PubMed ID: 457784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibroblasts transformed by an oncogenic virus show decreased uptake of puromycin aminonucleoside.
    Studzinski GP; Albanese EA; Scatina J; Trocola-Simchera M
    Biochem Biophys Res Commun; 1980 Aug; 95(4):1446-51. PubMed ID: 6251841
    [No Abstract]   [Full Text] [Related]  

  • 14. Determination of ionization sites and pK values in puromycin and puromycin aminonucleoside by 13C and 1H magnetic resonance.
    Narula SS; Dhingra MM
    Indian J Biochem Biophys; 1986 Dec; 23(6):306-15. PubMed ID: 3596624
    [No Abstract]   [Full Text] [Related]  

  • 15. Peptidyl transferase substrate specificity with nonaromatic aminoacyl analogues of puromycin.
    Fong KL; Vince R
    J Med Chem; 1978 Aug; 21(8):792-5. PubMed ID: 691004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and antimicrobial activity of 2'-deoxypuromycin.
    Koizumi F; Oritani T; Yamashita K
    Agric Biol Chem; 1990 Dec; 54(12):3093-7. PubMed ID: 1368634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Failure of angiotensin converting enzyme inhibition to affect the course of chronic puromycin aminonucleoside nephropathy.
    Marinides GN; Groggel GC; Cohen AH; Cook T; Baranowski RL; Westenfelder C; Border WA
    Am J Pathol; 1987 Nov; 129(2):394-401. PubMed ID: 2823616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterologous enzyme immunoassay for puromycin aminonucleoside using beta-D-galactosidase as a label.
    Fujiwara K; Ono S; Fujinaka H; Kitagawa T
    J Immunol Methods; 1984 Aug; 72(1):109-18. PubMed ID: 6431006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of puromycin and puromycin aminonucleoside with poly (A)--a proton magnetic resonance investigation.
    Dhingra MM; Narula SS
    Indian J Biochem Biophys; 1986 Dec; 23(6):316-21. PubMed ID: 3036691
    [No Abstract]   [Full Text] [Related]  

  • 20. DMSO potentiates aminonucleoside of puromycin nephrosis in rats.
    Spear GS; Nguyen D; Conklin S; Wikle JS; Fan J; Lan YH; Allen J; Reineck S
    J Pathol; 1987 Oct; 153(2):183-7. PubMed ID: 3694323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.